BBA
REGN icon

Baader Bank Aktiengesellschaft’s Regeneron Pharmaceuticals REGN Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,400
Closed -$2.83M – 588
2025
Q2 		$2.83M Buy
+5,400
New +$3.01M 0.2% 102

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Baader Bank Aktiengesellschaft's REGN Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft increased its Regeneron Pharmaceuticals (REGN) stake by 139% in Q1 2026, buying an estimated $3.03M and bringing the position to 6,811 shares worth $5.26M. The position accounts for 0.41% of the portfolio, ranked #58.

Baader Bank Aktiengesellschaft first reported a position in REGN in Q4 2021 and has held it in 17 quarters since. The position peaked at $7.5M in Q2 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Baader Bank Aktiengesellschaft held 6,811 shares of Regeneron Pharmaceuticals worth $5.26M as of Q1 2026.
  • Baader Bank Aktiengesellschaft bought 3,958 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $3.03M.
  • Regeneron Pharmaceuticals made up 0.41% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #58 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 17 quarters since.
  • Baader Bank Aktiengesellschaft's Regeneron Pharmaceuticals position peaked at $7.5M in Q2 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.